Brief: Aptose Biosciences Establishes New At-The-Market Facility
05/05/2020 22:43
May 5 (Reuters) - Aptose Biosciences Inc APS.TO :
* APTOSE BIOSCIENCES ESTABLISHES NEW AT-THE-MARKET FACILITY
* APTOSE BIOSCIENCES - WILL FILE PROSPECTUS SUPPLEMENT WITH
SEC,
QUALIFYING OFFER & SALE OF SHARES HAVING OFFERING PRICE OF UPTO
US$75 MILLION
Source text for Eikon: ID:nGNX5fhmsp
Further company coverage: APS.TO
(Reuters.Briefs@thomsonreuters.com)
Recent news on Aptose Biosciences
See all newsBrief: Aptose Biosciences Says Closing Of Arrangement With Hanmi Pharmaceutical Further Delayed
Brief: Aptose Reports First Quarter 2026 Results
Brief: Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan Of Arrangement
Brief: Leading Independent Proxy Advisory Firm Iss Recommends Aptose Biosciences Shareholders Vote “For” Proposed Plan Of Arrangement With Hanmi Pharmaceutical
Brief: Aptose Biosciences Announces Amendment To Arrangement Agreement And Details Of Shareholders Meeting